5U7M image
Deposition Date 2016-12-12
Release Date 2017-08-30
Last Version Date 2024-10-09
Entry Detail
PDB ID:
5U7M
Title:
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies PGT122 and 35O22 at 3.8 Angstrom
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.03 Å
R-Value Free:
0.28
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 63
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp160
Gene (Uniprot):env
Chain IDs:A (auth: B)
Chain Length:153
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:35O22 FAB HEAVY CHAIN
Chain IDs:B (auth: D)
Chain Length:243
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:35O22 FAB LIGHT CHAIN
Chain IDs:C (auth: E)
Chain Length:216
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp160
Gene (Uniprot):env
Chain IDs:D (auth: G)
Chain Length:481
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:PGT122 FAB HEAVY CHAIN
Chain IDs:E (auth: H)
Chain Length:235
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:PGT122 FAB LIGHT CHAIN
Chain IDs:F (auth: L)
Chain Length:213
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529.
Nat. Chem. Biol. 13 1115 1122 (2017)
PMID: 28825711 DOI: 10.1038/nchembio.2460

Abstact

The HIV-1 envelope (Env) spike is a conformational machine that transitions between prefusion (closed, CD4- and CCR5-bound) and postfusion states to facilitate HIV-1 entry into cells. Although the prefusion closed conformation is a potential target for inhibition, development of small-molecule leads has been stymied by difficulties in obtaining structural information. Here, we report crystal structures at 3.8-Å resolution of an HIV-1-Env trimer with BMS-378806 and a derivative BMS-626529 for which a prodrug version is currently in Phase III clinical trials. Both lead candidates recognized an induced binding pocket that was mostly excluded from solvent and comprised of Env elements from a conserved helix and the β20-21 hairpin. In both structures, the β20-21 region assumed a conformation distinct from prefusion-closed and CD4-bound states. Together with biophysical and antigenicity characterizations, the structures illuminate the allosteric and competitive mechanisms by which these small-molecule leads inhibit CD4-induced structural changes in Env.

Legend

Protein

Chemical

Disease

Primary Citation of related structures